Superworth

NutriBand price to sales ratio NTRB

Market value divided by revenue over the last twelve months, since 2021.

Today, Nov 2, 2026
48.2×
5-year median
22.3×
Against its 5-year history
97th
percentile: 0 is its lowest day, 100 its highest
5-year range
7.3× to 61.1×
Peer median
1.5×

NutriBand's price to sales ratio is 48.2× as of Nov 2, 2026.

That is above its 5-year median of 22.3×, higher than on 97% of days in the last 5 years.

Over that time it ranged from 7.3× in Oct 2023 to 61.1× in Sep 2026.

The median for 9 medical instruments and supplies stocks of a similar size is 1.5×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far48.2×19.2×61.1×
202525.7×22.3×46.9×
202421.1×9.0×48.7×
20238.7×7.3×19.0×
202213.8×13.6×33.8×
202152.5×18.9×52.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest NutriBand's size, closest first, today.

CompanyPrice to sales ratio
NTRBNutriBand48.2×
KEQUKewaunee Scientific0.3×
APTAlpha Pro Tech0.9×
NEPHNephros1.7×
PDEXPro DEX2.3×
UTMDUtah Medical Products6.2×
INFUInfuSystem1.9×
EMBCEmbecta0.3×
TCMDTactile Systems Technology1.5×
MOVMovado1.0×
Peer median1.5×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on NutriBand

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.